A professional and consumer nutritional company sought new opportunities for nutritional supplementation.  They identified COPD as an area of unmet need, but knew little about the disease and its treatment.  We mapped the patient pathway and facilitated two top level workshops to identify opportunities for them to pursue.

A large medtech company wanted to improve the effectiveness of a common orthopedic procedure in order to better position their products with payers.  We mapped out the patient pathway for the procedure and highlighted areas where they could partner with payers, patients, and providers to add value.

A large global pharmaceutical company had identified auto-immune disorders as key targets for their R&D organization.  We conducted a Multi-Variable Analysis of a range of auto-immune diseases to evaluate opportunities while remaining product agnostic.

A large pharmaceutical company in partnership with a leading biologics company were preparing for the launch of a blockbuster monoclonal antibody in immunology.  They had full development programs for two indications in place, but felt the compound could address a variety of additional indications.  We conducted a Multi-Variable Analysis to recommend disease areas that provided opportunity and fit with this biologic.